{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T13:49:29Z","timestamp":1767275369407,"version":"3.37.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gastrointestinal Infections at University of Liverpool in partnership with Public Health England"},{"DOI":"10.13039\/501100000736","name":"University of East Anglia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000736","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Oxford and the Quadram Institute"},{"name":"Claire Jenkins is based at Public Health England"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The implementation by diagnostic laboratories in England of polymerase chain reaction (PCR) to screen faecal specimens for Shiga toxin-producing Escherichia coli (STEC) has resulted in a significant increase in notifications mainly due to non-O157 strains. The purpose of this study was to develop an approach to public health risk assessment that prioritizes follow-up to cases caused by haemolytic uraemic syndrome (HUS) associated E. coli (HUSEC) strains and minimizes unnecessary actions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Epidemiological and microbiological data were prospectively collected from 1 November 2013 to 31 March 2017 and used to compare three risk assessment approaches.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A history of HUS\/bloody diarrhoea\/age under 6 years and faecal specimens positive for stx-predicted HUSEC with a diagnostic accuracy of 84% (95% CI; 81\u201388%). STEC isolated by Gastrointestinal Bacteria Reference Unit (GBRU) and stx2 and eae positive predicted HUSEC with a diagnostic accuracy of 99% (95% CI; 98\u2013100%). Risk assessment combining these two tests predicts the most efficient use of resources, predicting that 18% (97\/552) of cases would be eligible for follow-up at some stage, 16% (86\/552) following local stx PCR results, 1% (7\/552) following GBRU results of stx2 and eae status and 0.7% (4\/552) following whole-genome sequencing. Follow-up could be stopped in 78% (76\/97) of these cases, 97% (74\/76) following second stage risk assessment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This three-stage risk assessment approach prioritizes follow-up to HUSEC and minimizes unnecessary public health actions. We developed it into the algorithm for public health actions included in the updated PHE Guidance for management of STEC published in August 2018.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurpub\/ckaa232","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T12:37:08Z","timestamp":1606826228000},"page":"576-582","source":"Crossref","is-referenced-by-count":5,"title":["Shiga toxin-producing <i>Escherichia coli<\/i> diagnosed by Stx PCR: assessing the public health risk of non-O157 strains"],"prefix":"10.1093","volume":"31","author":[{"given":"K.J","family":"Carroll","sequence":"first","affiliation":[{"name":"Surrey and Sussex Health Protection Team, Public Health England South East, Horsham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Jenkins","sequence":"additional","affiliation":[{"name":"National Infection Service, Public Health England, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Harvey-Vince","sequence":"additional","affiliation":[{"name":"Surrey County Council Public Health Department, Kingston-Upon-Thames, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Mohan","sequence":"additional","affiliation":[{"name":"Thames Valley Health Protection Team, Public Health England South East, Chilton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Balasegaram","sequence":"additional","affiliation":[{"name":"Field Service South East & London, Public Health England, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"2021071319325655000_ckaa232-B1","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.2527\/jas.2006-508","article-title":"Shiga toxin-producing Escherichia coli: an overview","volume":"85","author":"Gyles","year":"2007","journal-title":"J Anim Sci"},{"key":"2021071319325655000_ckaa232-B2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1099\/jmm.0.075895-0","article-title":"Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009\u20132013","volume":"63","author":"Byrne","year":"2014","journal-title":"J Med Microbiol"},{"key":"2021071319325655000_ckaa232-B3","first-page":"5967","article-title":"Scientific opinion on the pathogenicity assessment of Shiga toxin-producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC","volume":"18","author":"Panel","year":"2020","journal-title":"EFSA J"},{"key":"2021071319325655000_ckaa232-B4","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EHEC-0019-2013","article-title":"Taxonomy meets public health: the case of Shiga toxin-producing Escherichia coli","volume":"2","author":"Scheutz","year":"2014","journal-title":"Microbiol Spectr"},{"key":"2021071319325655000_ckaa232-B5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12879-015-1017-6","article-title":"Shiga toxin-producing Escherichia coli infections in Norway, 1992\u20132012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome","volume":"15","author":"Brandal","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2021071319325655000_ckaa232-B6","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1017\/S0950268819001602","article-title":"The importance of integrating genetic strain information for managing cases of Shiga toxin-producing E. coli infection","volume":"147","author":"Werber","year":"2019","journal-title":"Epidemiol Infect"},{"key":"2021071319325655000_ckaa232-B7","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1128\/JCM.02591-06","article-title":"Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations","volume":"45","author":"Persson","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2021071319325655000_ckaa232-B8","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/toxins7062306","article-title":"Reduced toxicity of Shiga toxin (Stx) type 2c in mice compared to Stx2d is associated with instability of Stx2c holotoxin","volume":"7","author":"Bunger","year":"2015","journal-title":"Toxins (Basel)"},{"key":"2021071319325655000_ckaa232-B9","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1128\/IAI.00149-16","article-title":"Affinity-based screening of tetravalent peptides identifies subtype-selective neutralizers of Shiga toxin 2d, a highly virulent subtype, by targeting a unique amino acid involved in its receptor recognition","volume":"84","author":"Mitsui","year":"2016","journal-title":"Infect Immun"},{"year":"2010","key":"2021071319325655000_ckaa232-B10"},{"year":"2014","key":"2021071319325655000_ckaa232-B11"},{"key":"2021071319325655000_ckaa232-B12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1099\/jmm.0.000970","article-title":"The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public health","volume":"68","author":"Carroll","year":"2019","journal-title":"J Med Microbiol"},{"key":"2021071319325655000_ckaa232-B13"},{"year":"2016","key":"2021071319325655000_ckaa232-B14"},{"key":"2021071319325655000_ckaa232-B15","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD Group. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"2021071319325655000_ckaa232-B16","first-page":"203","article-title":"Measures of diagnostic accuracy: basic definitions","volume":"19","author":"\u0160imundi\u0107","year":"2009","journal-title":"EJIFCC"},{"key":"2021071319325655000_ckaa232-B17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10096-007-0420-3","article-title":"Relationship between pathogenicity for humans and stx genotype in Shiga toxin producing Escherichia coli serotype O157","volume":"27","author":"Kawano","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021071319325655000_ckaa232-B18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/338115","article-title":"Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms","volume":"185","author":"Friedrich","year":"2002","journal-title":"J Infect Dis"},{"key":"2021071319325655000_ckaa232-B19","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1128\/JCM.40.12.4585-4593.2002","article-title":"Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles","volume":"40","author":"Eklund","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2021071319325655000_ckaa232-B20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/JCM.42.3.1099-1108.2004","article-title":"Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period","volume":"42","author":"Beutin","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2021071319325655000_ckaa232-B21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"2021071319325655000_ckaa232-B22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4315\/0362-028X.JFP-18-291","article-title":"Hazard identification and characterization: criteria for categorizing Shiga toxin-producing Escherichia coli on a risk basis","volume":"82","year":"2019","journal-title":"J Food Prot"},{"key":"2021071319325655000_ckaa232-B23","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1128\/JCM.41.11.4930-4940.2003","article-title":"Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and\/or serious disease","volume":"41","author":"Karmali","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2021071319325655000_ckaa232-B24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/JCM.03590-14","article-title":"Assessing the public health risk of Shiga toxin producing Escherichia coli by use of a rapid diagnostic screening algorithm","volume":"53","author":"de Boer","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2021071319325655000_ckaa232-B25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/eurpub\/ckz132","article-title":"A practical composite risk score for the development of Haemolytic Uraemic Syndrome from Shiga toxin-producing Escherichia coli","volume":"29","author":"Hamilton","year":"2019","journal-title":"Eur J Public Health"},{"key":"2021071319325655000_ckaa232-B26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10096-019-03475-5","article-title":"Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007\u20132017","volume":"38","author":"Jenssen","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021071319325655000_ckaa232-B27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fcimb.2018.00125","article-title":"Shiga toxin-producing Escherichia coli infection in J\u00f6nk\u00f6ping County, Sweden: occurrence and molecular characteristics in correlation with clinical symptoms and duration of stx shedding","volume":"8","author":"Bai","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"year":"2012","author":"Tam","key":"2021071319325655000_ckaa232-B28"},{"key":"2021071319325655000_ckaa232-B29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/cid\/cis028","article-title":"Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from two prospective, population-based studies of infectious intestinal disease","volume":"54","author":"Tam","year":"2012","journal-title":"Clin Infect Dis"},{"year":"2015","key":"2021071319325655000_ckaa232-B30"},{"key":"2021071319325655000_ckaa232-B31","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3201\/eid2209.160477","article-title":"Changing diagnostic methods and increased detection of verotoxigenic Escherichia coli","volume":"22","author":"Rice","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2021071319325655000_ckaa232-B32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1469-0691.2008.01963.x","article-title":"Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands","volume":"14","author":"van Duynhoven","year":"2008","journal-title":"Clin Microbiol Inf"},{"key":"2021071319325655000_ckaa232-B33","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa1106482","article-title":"German outbreak of Escherichia coli O104: H 4 associated with sprouts","volume":"365","author":"Buchholz","year":"2011","journal-title":"N Engl J Med"},{"key":"2021071319325655000_ckaa232-B34","doi-asserted-by":"crossref","first-page":"30610","DOI":"10.2807\/1560-7917.ES.2017.22.36.30610","article-title":"Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55: H 7 Stx2a) in the south west of England, July 2014 to September 2015","volume":"22","author":"McFarland","year":"2017","journal-title":"Euro Surveill"},{"key":"2021071319325655000_ckaa232-B35","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3201\/eid2209.160304","article-title":"Enterohemorrhagic Escherichia coli hybrid pathotype O80: H 2 as a new therapeutic challenge","volume":"22","author":"Soysal","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2021071319325655000_ckaa232-B36","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1128\/JB.00480-08","article-title":"Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli","volume":"190","author":"Konczy","year":"2008","journal-title":"JB"},{"key":"2021071319325655000_ckaa232-B37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4315\/0362-028X.JFP-16-296","article-title":"Detection and isolation of the \u201cTop Seven\u201d Shiga toxin-producing Escherichia coli in ground beef: comparison of RapidFinder kits to the U.S. Department of Agriculture Microbiology Laboratory Guidebook method","volume":"80","author":"Fratamico","year":"2017","journal-title":"J Food Prot"},{"key":"2021071319325655000_ckaa232-B38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1099\/jmm.0.001136","article-title":"Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing Escherichia coli from faecal specimens","volume":"69","author":"Jenkins","year":"2020","journal-title":"J Med Microbiol"},{"year":"2018","key":"2021071319325655000_ckaa232-B39"}],"container-title":["European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurpub\/article-pdf\/31\/3\/576\/38939852\/ckaa232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurpub\/article-pdf\/31\/3\/576\/38939852\/ckaa232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T19:35:00Z","timestamp":1626204900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article\/31\/3\/576\/6067613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,1,7]]},"published-print":{"date-parts":[[2021,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckaa232","relation":{},"ISSN":["1101-1262","1464-360X"],"issn-type":[{"type":"print","value":"1101-1262"},{"type":"electronic","value":"1464-360X"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,1,7]]}}}